GLP-1 pharmaceutical compositions
US8236759B2 · kind B2 · utility
0Cited by
20References
45Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 30, 2006 |
| Grant date | Aug 7, 2012 |
| Priority date | — |
| Expiry date | Feb 23, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P3/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to peptide analogues of glucagon-like peptide-1, the pharmaceutically-acceptable salts thereof, to methods of using such analogues to treat mammals and to pharmaceutical compositions useful therefore comprising said analogues.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.